Title:
COMPOSITION WHICH CONTAINS LACTIC ACID BACTERIUM AS EFFECTIVE COMPONENT AND WHICH IS FOR PREVENTING OR AMELIORATING SKIN CONDITION DETERIORATION CAUSED BY ABNORMAL PROLIFERATION OF SPECIFIC BACTERIUM IN SKIN
Document Type and Number:
WIPO Patent Application WO/2018/051895
Kind Code:
A1
Abstract:
Provided is a drug composition and food composition for treating or preventing a skin disease caused by the abnormal proliferation of a skin bacterium or caused by pathogenic microbe infection. This composition includes lactic acid bacterium as an effective component, and is taken orally for suppressing abnormal bacterial proliferation or for preventing or ameliorating skin condition deterioration caused by abnormal bacterial proliferation.
Inventors:
TSUJI RYOHEI (JP)
FUJII TOSHIO (JP)
FUJII TOSHIO (JP)
Application Number:
PCT/JP2017/032330
Publication Date:
March 22, 2018
Filing Date:
September 07, 2017
Export Citation:
Assignee:
KIRIN CO LTD (JP)
International Classes:
A61K35/744; A23L33/135; A61P17/00; A61P17/02; A61P17/10; A61P31/04; C12N1/20; C12N15/09
Foreign References:
| JP2014513106A | 2014-05-29 | |||
| US20090214497A1 | 2009-08-27 | |||
| JP2016508712A | 2016-03-24 | |||
| JP2007537224A | 2007-12-20 | |||
| US20080233091A1 | 2008-09-25 | |||
| JP2003259860A | 2003-09-16 | |||
| JP2002171933A | 2002-06-18 |
Other References:
CHARLIER, CATHY ET AL.: "Acidification is not involved in the early inhibition of Staphylococcus aureus growth by Lactococcus lactis in milk", INT. DAIRY J., vol. 18, 2008, pages 197 - 203, XP022368393, DOI: doi:10.1016/j.idairyj.2007.03.015
Attorney, Agent or Firm:
HIRAKI & ASSOCIATES (JP)
Download PDF: